⌘K

Login Start Free

Home/Filings/4/0001104659-23-057260

4//SEC Filing

Gruia Gabriela 4

Accession 0001104659-23-057260

CIK 0001781983other

View on SEC.gov Company Profile

Filed

May 7, 8:00 PM ET

Accepted

May 8, 5:17 PM ET

Size

5.3 KB

Accession

0001104659-23-057260

Insider Transaction Report

Form 4

Period: 2023-05-05

Aprea Therapeutics, Inc.APRE

Director

Transactions

Award
Stock Options (Right to Buy)
2023-05-05+12,500→ 12,500 total
Exercise: $3.90Exp: 2033-05-05→ Common Stock (12,500 underlying)

Footnotes (1)

[F1]These options shall vest in full on May 5, 2024, subject to the reporting person's continued service through and including the applicable vesting date.

Documents

1 file

4
tm2314936-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Aprea Therapeutics, Inc.

CIK 0001781983

Entity typeother

Related Parties

1

filerCIK 0001860326

Filing Metadata

Form type: 4
Filed: May 7, 8:00 PM ET
Accepted: May 8, 5:17 PM ET
Size: 5.3 KB

View on SEC.gov